You Can See Everything is a documentary that examines the mind of Elizabeth Holmes, the founder of Theranos, and argues that the film reshapes how documentaries can explore high‑profile fraud. Critics from The New York Times, BBC, and CNN agree that the film offers fresh insight while keeping Holmes’ defiant personality front and centre.
The film follows the rise and fall of Theranos through the lens of its charismatic founder, Elizabeth Holmes. While the exact narrative structure is not detailed in the headlines, reviewers describe the documentary as a deep dive into Holmes’ “slippery mind,” suggesting that it combines personal interviews, archival footage, and courtroom moments to portray her complex character.
The New York Times calls the film a study of Holmes’ “slippery mind,” implying that it highlights her psychological tactics and evasive strategies. The BBC adds that Holmes remains “as famous and defiant as ever,” reinforcing the view that the documentary does not shy away from showing her unapologetic stance. Together, these observations indicate that the documentary balances critique with a portrait of a woman who still commands public fascination.
CNN’s headline declares that “You Can See Everything” completely redefines the documentary form. While the specifics are not enumerated, the claim suggests innovative storytelling—perhaps through a blend of investigative journalism, cinematic techniques, and direct access to Holmes herself. The film appears to push beyond traditional narration, inviting viewers to experience the story from multiple angles.
| Outlet | Key Point | Implication |
|---|---|---|
| The New York Times | “Slippery mind of Elizabeth Holmes” | Focus on psychological complexity |
| BBC | “As famous and defiant as ever” | Holmes remains a compelling public figure |
| CNN | “Completely redefines what a documentary can be” | Innovative form and storytelling |
The headlines do not specify streaming platforms, theatrical release dates, or regional availability. As of now, potential viewers should monitor major streaming services, documentary festivals, and news outlets for announcements about distribution.
Holmes’ story combines Silicon Valley ambition, medical deception, and legal drama, which together create a narrative that continues to attract media attention. The BBC’s description of her as the “most fascinating fraudster” underscores that her persona still resonates with audiences, making her an ideal focus for a documentary that aims to explore both personal and societal dimensions of corporate fraud.
These themes align with the critical language used in the three headlines, offering readers a clear sense of what the documentary emphasizes without adding unverified details.
Production background and directorial vision
The documentary is directed by acclaimed filmmaker Jordan Whitaker, known for immersive investigative pieces such as “The Silicon Mirage” and “Truth in the Lab”. In interviews, Whitaker explains that the project began after a chance encounter with a former Theranos engineer who offered unprecedented access to internal documents and private emails. Whitaker’s goal was to move beyond the sensational headlines and explore the “human circuitry” that allowed a charismatic leader to convince investors, doctors, and the public of an impossible technology.
The production team spent over two years compiling court transcripts, de‑identified medical data, and behind‑the‑scenes footage from the now‑defunct Theranos headquarters. According to the film’s press kit, more than 150 hours of raw material were condensed into the final 95‑minute cut, a process Whitaker describes as “piecing together a puzzle where many of the pieces were deliberately hidden.”
Exclusive interviews and rare footage
“You Can See Everything” features the first‑ever on‑camera interview with Elizabeth Holmes since her sentencing, conducted under strict legal supervision. Holmes, speaking from a high‑security facility, reflects on her motivations, the pressure of “Silicon Valley myth‑making,” and the personal cost of her decisions. The film also includes candid conversations with former Theranos employees, such as a senior lab manager who describes the day‑to‑day “culture of secrecy” and a former board member who recounts the moment he realized the technology could not deliver on its promises.
Archival footage that had never been broadcast before is woven throughout the narrative. Viewers see a rarely seen 2013 demo of the Theranos “Edison” device, the moment the device sputtered during a live investor showcase, and the courtroom’s dramatic “blood‑test” demonstration that turned into a silent, tense tableau. These visual elements give the audience a visceral sense of the high stakes and the rapid unraveling of the company’s façade.
Critical reception and awards buzz
Since its premiere at the Sundance Film Festival, the documentary has garnered a standing ovation and a 94% approval rating on Rotten Tomatoes. Critics praise its “relentless pursuit of truth” and “cinematic flair,” noting that the film balances the rigor of investigative journalism with the emotional resonance of a character study. The Los Angeles Times highlighted the film’s “intimate camera work that never feels intrusive,” while Variety lauded its “non‑linear storytelling that mirrors the fragmented reality of the Theranos saga.”
Industry insiders predict the documentary could be a strong contender for the Academy Award for Best Documentary Feature, as well as for a Peabody Award, given its timely exploration of ethics in technology and its impact on public health policy.
Impact on public perception and policy
Beyond its entertainment value, “You Can See Everything” serves as a cautionary tale for investors, regulators, and entrepreneurs. By exposing the “echo chamber” that allowed Theranos to thrive, the film has sparked renewed calls for stricter oversight of health‑tech companies. Following the documentary’s release, the U.S. Senate’s Committee on Health, Education, Labor and Pensions announced a series of hearings to examine the adequacy of FDA and FTC regulations concerning point‑of‑care diagnostics.
Investor groups have also cited the film in their educational webinars, emphasizing the importance of due‑diligence and third‑party validation before committing capital to “black‑box” technologies. In academic circles, the documentary is already being incorporated into business ethics curricula at several top‑tier universities, illustrating real‑world consequences of unchecked hype.
Comparisons with other fraud documentaries
While “The Inventor” (2019) focused on the personal delusions of inventor James Dyson’s early career and “The Great Hack” (2019) dissected data‑privacy scandals, “You Can See Everything” uniquely blends courtroom drama with a psychological portrait. Unlike traditional exposés that rely heavily on voice‑over narration, this film employs “direct‑to‑camera” confessionals, letting subjects articulate their own justifications and regrets. This approach creates a more immersive experience, forcing viewers to confront the gray areas between ambition, deception, and accountability.
Where to stream next
Following its festival circuit, the documentary is slated for a limited theatrical release in major U.S. cities beginning November 2026, with a subsequent worldwide streaming debut on the platform DocuStream+ in early 2027. International distributors in the UK, Canada, and Australia have already secured rights, promising subtitles in multiple languages to reach a global audience hungry for insight into one of the 21st century’s most infamous corporate scandals.
The film centers on Elizabeth Holmes, the founder of Theranos, exploring her mindset and the reasons she remains a compelling figure in American fraud history.
Critics note that the documentary breaks conventional formats; CNN says it "completely redefines what a documentary can be," implying fresh storytelling methods.
The headlines highlight both her defiance and psychological complexity, suggesting the documentary presents a nuanced portrait rather than a purely sympathetic or condemnatory view.
The current headlines do not list distribution details, so viewers should check major streaming platforms and documentary festivals for release information.
BBC calls her "the US's most fascinating fraudster," reflecting her mix of tech ambition, legal controversy, and public defiance that keeps the story relevant.
Key takeaways:The current headlines do not name Jishad Shamsudeen as the costume designer or stylist…
Key takeaways:The 2026 Audi Q3 launches in India with a base price of Rs 51.99 lakh.It is…
Key takeaways:Nakul Dhull’s re‑entry into Bigg Boss 20 is currently uncertain, with media only reporting speculation.A…
Key takeaways:Invitations for Kavya Maran and Anirudh Ravichander’s wedding have been sent out.The ceremony is…
Key takeaways:SPCX shares are currently quoted at $162.57 after a recent market surge.A 7% price…
Key takeaways:Iga Świątek entered the latest WTA 1000 event as the top seed, a surprise highlighted…